Scutellarin Alleviates Behavioral Deficits in a Mouse Model of Multiple Sclerosis, Possibly Through Protecting Neural Stem Cells

[1]  Xiaoling Guo,et al.  bFGF and Activin A function to promote survival and proliferation of single iPS cells in conditioned half-exchange mTeSR1 medium , 2015, Human Cell.

[2]  Milton L. Greenberg,et al.  Two-photon imaging of remyelination of spinal cord axons by engrafted neural precursor cells in a viral model of multiple sclerosis , 2014, Proceedings of the National Academy of Sciences.

[3]  Yang Liu,et al.  Scutellarin and caffeic acid ester fraction, active components of Dengzhanxixin injection, upregulate neurotrophins synthesis and release in hypoxia/reoxygenation rat astrocytes. , 2013, Journal of ethnopharmacology.

[4]  Jia-he Wang,et al.  Pseudolaric acid B induces apoptosis in U937 human leukemia cells via caspase-9‑mediated activation of the mitochondrial death pathway. , 2013, Molecular medicine reports.

[5]  A. Hedayatpour,et al.  Promotion of Remyelination by Adipose Mesenchymal Stem Cell Transplantation in A Cuprizone Model of Multiple Sclerosis , 2013, Cell journal.

[6]  Z. Guan,et al.  The neurotoxicity of β-amyloid peptide toward rat brain is associated with enhanced oxidative stress, inflammation and apoptosis, all of which can be attenuated by scutellarin. , 2013, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[7]  T. Lane,et al.  MHC Mismatch Results in Neural Progenitor Cell Rejection Following Spinal Cord Transplantation in a Model of Viral‐Induced Demyelination , 2012, Stem cells.

[8]  Yang Liu,et al.  Neuroprotective effects of scutellarin against hypoxic-ischemic-induced cerebral injury via augmentation of antioxidant defense capacity. , 2011, The Chinese journal of physiology.

[9]  L. Hu,et al.  Neuroprotection of Scutellarin is mediated by inhibition of microglial inflammatory activation , 2011, Neuroscience.

[10]  H. Woo,et al.  Differential Regulation of Proliferation and Differentiation in Neural Precursor Cells by the Jak Pathway , 2010, Stem cells.

[11]  R. Franklin,et al.  Stem cell transplantation in multiple sclerosis: current status and future prospects , 2010, Nature Reviews Neurology.

[12]  Z. Berente,et al.  Inhibiting poly(ADP-ribose) polymerase: a potential therapy against oligodendrocyte death. , 2010, Brain : a journal of neurology.

[13]  Sjef Copray,et al.  The cuprizone animal model: new insights into an old story , 2009, Acta Neuropathologica.

[14]  M. Calcagnotto,et al.  Effects of FGF-2 and EGF removal on the differentiation of mouse neural precursor cells. , 2009, Anais da Academia Brasileira de Ciencias.

[15]  S. Ferrari,et al.  Regeneration and repair in multiple sclerosis: The role of cell transplantation , 2009, Neuroscience Letters.

[16]  Yunhua Zhu,et al.  Wip1 Regulates the Generation of New Neural Cells in the Adult Olfactory Bulb through p53‐Dependent Cell Cycle Control , 2009, Stem Cells.

[17]  H. Weiner,et al.  The challenge of multiple sclerosis: How do we cure a chronic heterogeneous disease? , 2009, Annals of neurology.

[18]  Guang-Xian Zhang,et al.  Cellular remyelinating therapy in multiple sclerosis , 2009, Journal of the Neurological Sciences.

[19]  H. Wekerle.  Lessons from multiple sclerosis: models, concepts, observations , 2008, Annals of the rheumatic diseases.

[20]  V. Balasubramaniyan,et al.  Oligodendrocyte differentiation and implantation: new insights for remyelinating cell therapy. , 2008, Current opinion in neurology.

[21]  C. Wegner,et al.  Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. , 2008, Brain : a journal of neurology.

[22]  D. Dembélé,et al.  Bcl2, a transcriptional target of p38α, is critical for neuronal commitment of mouse embryonic stem cells , 2008, Cell Death and Differentiation.

[23]  L. Yiming,et al.  Neuroprotective effects of breviscapine against apoptosis induced by transient focal cerebral ischaemia in rats , 2008, The Journal of pharmacy and pharmacology.

[24]  Wei Xu,et al.  Effects of scutellarin on PKCγ in PC12 cell injury induced by oxygen and glucose deprivation , 2007, Acta Pharmacologica Sinica.

[25]  D. Su,et al.  Protective Effects of Scutellarin and Breviscapine on Brain and Heart Ischemia in Rats , 2007, Journal of cardiovascular pharmacology.

[26]  H. Hong,et al.  Scutellarin protects PC12 cells from oxidative stress-induced apoptosis , 2006, Journal of Asian natural products research.

[27]  X. Fang,et al.  cAMP‐induced differentiation of human neuronal progenitor cells is mediated by nuclear fibroblast growth factor receptor‐1 (FGFR1) , 2003, Journal of neurochemistry.

[28]  W. Cammer.  The neurotoxicant, cuprizone, retards the differentiation of oligodendrocytes in vitro , 1999, Journal of the Neurological Sciences.

[29]  E. M. Carey,et al.  Biochemical changes in cuprizone-induced spongiform encephalopathy , 1983, Neurochemical Research.

[30]  K. Suzuki,et al.  Status spongiosus of CNS and hepatic changes induced by cuprizone (biscyclohexanone oxalyldihydrazone). , 1969, The American journal of pathology.

[31]  S. Miller,et al.  Strategies for protecting oligodendrocytes and enhancing remyelination in multiple sclerosis. , 2013, Discovery medicine.

[32]  R. Franklin,et al.  Remyelination in experimental models of toxin-induced demyelination. , 2008, Current topics in microbiology and immunology.

[33]  W. Carlton,et al.  Studies on the induction of hydrocephalus and spongy degeneration by cuprizone feeding and attempts to antidote the toxicity. , 1967, Life sciences.